Did a Hedge Kill United Wholesale Mortgage? Really?

August 17, 2026 | Some observers think that United Wholesale Mortgage Corp (UWMC) collapsed into the arms of Oaktree Capital Management, a unit of Brookfield (BN), last month because they erroneously hedged potential exposure from a REIT called Two Harbors (TWO), a company UWMC ultimately did not buy. But this is wrong. TWO was fully hedged already.

UWMC collapsed because the CEO, Mat Ishbia, extracted hundreds of millions of dollars in cash from a company that was never really profitable. UWMC was run for volume, not profits. Indeed, his aggressive strategy for winning new residential loan business compressed profits across the entire mortgage industry. Debt and asset sales facilitated this canard. How did Mat Ishbia fool everyone for so long?

United Wholesale Mortgage investors are accusing the company and its leaders of securities fraud over their public statements, or lack of, regarding the lender's ill-fated hedge. But the alleged "hedge" regarding the effort to purchase Two Harbors is not what led to the financial collapse of the largest residential mortgage lender in the US.

Proceeds from Sale of Mortgage Servicing Rights ($000)

 Source: EDGAR

If we look at the public filings of UWMC, and compare them with other mortgage lenders such as Rocket Companies (RKT) and PennyMac (PFSI), it is pretty clear that UWMC paid dividends with the proceeds of unsecured debt, overvalued assets, and sales of mortgage servicing rights (MSRs), often below cost. This scheme was encouraged with fanciful presentations of company financials to attract capital from credulous retail investors and support from equally imprudent analysts.

In Q2 2026, for example, UWMC claimed to have a gain on sale of 133 basis points, which is 100% wholesale production. The comparable figure for PennyMac was 100bp and RKT was just 68bp. But wait, if UWMC was making so much more gain on sale than these other players, why didn’t RKT and PFSI pick up incremental market share? Because UWMC was overpaying for the loans. After all, UWMC has 40% market share.  

In fact, UWMC misrepresented their gain margin, as they call it, as revenue when it really represented a cash expense. UWMC had a stated gain margin in the 10-Q twice that of the other lenders. How did they do this? Were they really that profitable? The answer in the UWMC financials seems to be no.

If we drill down into their 10-Q (all of this information is from public filings), another explanation emerges. UWMC basically said their loan production income was $527.2 million, and their "gain margin" was 133 basis points. So that implied they did $39.6 billion of loans sold in Q2 2026.

The UWMC 10-Q says that they retained servicing on 95% of what loans they originated. This means that they retained servicing on $37.7 billion of originations. Their mortgage servicing rights or MSR table says they capitalized $1.04 billion, a little bit more, on that $37.7 billion in UPB. That implies 276.7 basis points of servicing retained.

If we do a little bit more digging into what the average servicing strip was at the end of the quarter versus the beginning of the quarter, and what their sales were, what their amortization was, it appears that they retained a 47 basis point servicing strip on that $37.7 billion. This would imply that they retained the MSR on a 5.9x multiple of annual servicing income (~ 30bp) on loans with about a 50-50 mix of conventionals and Ginnie Mae. But is that multiple right?

Today a 50-50 mix of conventionals and Ginnie Mae loans, in a secondary market loan sale, would be priced at a 4.5x multiple of annual cash flow. If you're lucky. This suggests that UWMC overpriced their MSR by 1.4x on that 47 bp strip, which by the way is about 70 basis points on unpaid principal balance (UPB) of the loan servicing retained. Take 133bp minus 70bp and this gets UWMC down into line with the gain-on-sale for RKT and PFSI. 

But here's the best part. In order to raise cash to staunch the red ink from operating losses, UWMC would sell MSRs into the secondary market below cost. UWMC would pay excessive prices for loans, sell the mortgage note into a securitization at a small cash loss but then sell the servicing asset at a 10-20% discount to secondary market cost, according to several national lenders. The result was a business that rarely made a profit.

Net Cash (Used In) Provided by Operating Activities ($000)

Source: EDGAR

Now the gain on sale by RKT or PFSI in the wholesale channel is cash, but the “gain margin” reported by UWMC in Q2 2026 appears to be an accounting gain. RKT reportedly sells the servicing from loans originated in the wholesale channel because any effort at retention is futile. PennyMac retains its wholesale MSR, as they disclose, but they do not solicit that portfolio for refinance for 18 months. 

So if UWMC overvalued their new origination servicing, then obviously they're probably overvaluing their entire MSR portfolio. This is where UWMC apparently decided to take an interest rate bet -- not a hedge. If they won Two Harbors and rode the servicing up to the levels where UWMC’s MSRs were marked for leverage purposes with lenders, Ishbia would get more borrowing capacity.  Viola. UWMC grew the fair value of MSRs 30% in the past six months, net of a $800 million cash sale.

So let’s further assume based upon the public disclosure the UWMC book value multiple on the total MSRs held is 5.36x annual cash flow. Let's assume that that's maybe three quarters of a multiple overvalued or ~ 30bp. This suggests that the UWMC assets are overvalued by about $750 million. If UWMC took that actual mark to the fair value of the MSR, it would knock their tangible book value down to just $230 million. UWMC operates on a razor thin cash reserve compared to other large lenders and has $3 billion in unsecured corporate debt.

Events of Noncompliance

So what happens next?  UWMC raised $1.65 billion at the end of Q2. A billion and a half from Oak Tree, $150 million from the Ishbia family. And the billion and a half is actually senior to the $150 million. There's an A1 preferred and an A2 preferred, respectively.

UWMC is supposed to do a “rights offering” in Q4 which is going to raise another $400 million. They will first offer it to existing shareholders as common stock at the greater of $2 or 85% of the weighted average price of the 10 days before November 12th of 2026.

Unless the UWMC stock's trading above to $2 by November, no common stockholder in their right mind is going to buy it.  Then the deal says, any amount of the $400 million that we don't raise, UWMC can raise through Oaktree. 

Oaktree has the choice of either accepting the terms of the rights offering that is offered to the public. Or they can take a class A3 preferred equity, which has basically the same terms as the A1 and A2, but it's subordinate to both. Oaktree is not going to put another $400 million up subordinate to their existing position. As it is Oaktree may never recover their original investment.  

So then the agreement goes on and says if neither of those parities raise the $400 million, the Ishbias are obligated to fund the $400 million at the same terms as Oaktree. So they can either take common at the greater of $2 or 85% or the A3 preferred.

Now this is where it gets really interesting. In the agreement with Oaktree, there is a provision referring to events of “noncompliance.” One of the events of noncompliance is if the tangible book value of the stock drops below zero when you exclude the preferred shares. Another occurs if the Ishbias fail to inject new capital when required.

So let's say that Oaktree demands that the books of UWMC be cleaned-up and the MSR write-off is $750 million. Then net worth drops basically down to zero and Ishbia is a whisker away from an event of noncompliance. In that event, Oaktree gets to name the majority of the board and takes over the company.

Allowing himself to be forced out of the company by not contributing another $400 million to the equity may be a convenient exit for Mat Ishbia. He could say he tried to support UWMC, but was forced out by Oaktree – this after putting in another $150 million in July. And Oaktree is left to try to salvage value from a mortgage lender that has not really been profitable going back years. 

Remember that UWMC sold $800 million in MSRs in 1H 2026, yet still the company required a $1.6 billion rescue. If Oaktree is now first in line in terms of dividends on its preferred shares, there will be nothing left for Ishbia or his long suffering common shareholders. Ishbia’s personal holding company, SFS, received hundreds of millions in dividends each year that were effectively funded with asset sales and corporate debt.

But the big question now for the industry and Oaktree is how much does the business model of UWMC need to change in order for the company to be really profitable? Industry gain-on-sale margins have been compressed for years by UWMC’s excessive bids for loans in the wholesale channel. Will profitability return to the residential mortgage industry now that Ishbia is no longer calling the shots? And what will it take for Oaktree to recover their $1.5 billion investment in United Wholesale Mortgage Corp?   

The Institutional Risk Analyst (ISSN 2692-1812) is published by Whalen Global Advisors LLC and is provided for general informational purposes only and is not intended for trading purposes or financial advice. By making use of The Institutional Risk Analyst web site and content, the recipient thereof acknowledges and agrees to our copyright and the matters set forth below in this disclaimer. Whalen Global Advisors LLC makes no representation or warranty (express or implied) regarding the adequacy, accuracy or completeness of any information in The Institutional Risk Analyst. Information contained herein is obtained from public and private sources deemed reliable. Any analysis or statements contained in The Institutional Risk Analyst are preliminary and are not intended to be complete, and such information is qualified in its entirety. Any opinions or estimates contained in The Institutional Risk Analyst represent the judgment of Whalen Global Advisors LLC at this time, and is subject to change without notice. The Institutional Risk Analyst is not an offer to sell, or a solicitation of an offer to buy, any securities or instruments named or described herein. The Institutional Risk Analyst is not intended to provide, and must not be relied on for, accounting, legal, regulatory, tax, business, financial or related advice or investment recommendations. Whalen Global Advisors LLC is not acting as fiduciary or advisor with respect to the information contained herein. You must consult with your own advisors as to the legal, regulatory, tax, business, financial, investment and other aspects of the subjects addressed in The Institutional Risk Analyst. Interested parties are advised to contact Whalen Global Advisors LLC for more information.